Abstract
Although thrombin is a critical enzyme in the coagulation cascade, it has become apparent that it has many other effects. Thus, it may induce brain edema formation, angiogenesis and cell proliferation. Because of the importance of these three factors in the extremely poor prognosis of glioma patients, the present study examined the role of thrombin in that disease state. We found that thrombin activity is increased in a rat glioma model and thrombin positive cells were present in the tumor. Anti-thrombin treatment with argatroban reduced brain edema, tumor growth, and tumorrelated neurological deficits. Our results suggest that thrombin is a new target for glioma treatment.
Supported by grants NS-17760 (JTH) and NS-39866 (GX) from the National Institutes of Health.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cavanaugh KP, Gurwitz D, Cunningham DD, Bradshaw RA (1990) Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J Neurochem 54: 1735–1743
Chinni C, de Niese MR, Tew DJ, Jenkins AL, Bottomley SP, Mackie EJ (1999) Thrombin, a survival factor for cultured myoblasts. J Biol Chem 274: 9169–9174
Gingrich MB, Traynelis SF (2000) Serine proteases and brain damage — is there a link? Trend Neurosci 23: 399–407
Hua Y, Schallert T, Keep RF, Wu J, Hoff JT, Xi G (2002) Behavioral tests after intracerebral hemorrhage in the rat. Stroke 33: 2478–2484
Lampson LA (2001) New animal models to probe brain tumor biology, therapy, and immunotherapy: advantages and remaining concerns. J Neuro Oncol 53: 275–287
Lee KR, Colon GP, Betz AL, Keep RF, Kim S, Hoff JT (1996) Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg 84: 91–96
Lee KR, Kawai N, Kim S, Sagher D, Hoff JT (1997) Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J Neurosurg 86: 272–278
Maragoudakis ME, Tsopanoglou NE (2000) On the mechanism(s) ofthrombin induced angiogenesis. Advances Exper Med Biol 476: 47–55
Maragoudakis ME, Tsopanoglou NE, Andriopoulou P, Maragoudakis MM (2000) Effects of thrombin/thrombosis in angiogenesisand tumour progression. Matrix Biol 19: 345–351
Medrano EE, Cafferata EG, Larcher F (1987) Role of thrombin in the proliferative response of T-47D mammary tumor cells. Mitogenic action and pleiotropic modifications induced together with epidermal growth factor and insulin. Exper Cell Res 172: 354–364
Neveu I, Jchan F, Jandrot-Perrus M, Wion D, Brachet P (1993) Enhancement of the synthesis and secretion of nerve growth factor in primary cultures of glial cells by proteases: a possible involvement ofthrombin. J Neurochem 60: 858–867
Nguyen M, Arkell J, Jackson CJ (1999) Thrombin rapidly and efficiently activates gelatinase A in human microvascular endothelial cells via a mechanism independent of active MT1 matrix metalloproteinase. Lab Investigat 79: 467–475
Nishino A, Suzuki M, Ohtani H, Motohashi D, Umezawa K, Nagura H, Yoshimoto T (1993) Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 10: 167–179
Ogiichi T, Hirashima Y, Nakamura S, Endo S, Kurimoto M, Takaku A (2000) Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation. J Neuro Oncol 46: 1–9
Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST (2000) GNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39: 777–787
Stoop AA, Lupu F, Pannekoek H (2000) Colocalization of thrombin, PAI-1, and vitronectin in the atherosclerotic vessel wall: a potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes. Arteriosclerosis, Thrombosis Vascular Biol 20: 1143–1149
Xi G, Keep RF, Hua Y, Xiang JM, Hoff JT (1999) Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 30: 1247–1255
Xi G, Wagner KR, Keep RF, Hua Y, de Courten-Myers GM, Broderick JP, Brott TG, Hoff JT (1998) The role of blood clot formation on early edema development following experimental intracerebral hemorrhage. Stroke 29: 2580–2586
Zacharski LR, Henderson WG, Rickles FR, Forman WB, Cornell CJ Jr, Forcier RJ, Edwards RL, Headley E, Kim SH, O’Donnell JF (1984) Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75. Cancer 53: 2046–2052
Zacharski LR, Ornstein DL (1998) Heparin and cancer. Thrombosis Haemostasis 80: 10–23
Zagzag D, Friedlander DR, Margolis B, Grumet M, Semenza GL, Zhong H, Simons JW, Holash J, Wiegand SJ, Yancopoulos GD (2000) Molecular events implicated in brain tumor angiogenesis and invasion. Pediatric Neurosurg 33: 49–55
Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, Semenza GL (2000) Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88: 2606–2618
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Wien
About this paper
Cite this paper
Hua, Y., Keep, R.F., Schallert, T., Hoff, J.T., Xi, G. (2003). A thrombin inhibitor reduces brain edema, glioma mass and neurological deficits in a rat glioma model. In: Kuroiwa, T., et al. Brain Edema XII. Acta Neurochirurgica Supplements, vol 86. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0651-8_103
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0651-8_103
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7220-9
Online ISBN: 978-3-7091-0651-8
eBook Packages: Springer Book Archive